Jeff Shortway, M.S.
2008-2014, Dr. Anthony Morielli’s lab
Thesis Defense March 13, 2014
"The effects of alpha-subunit composition on Kv1 family potassium channel modulation by RHOA"
2009-2014, Dr. Alan Howe's lab
Thesis Defense 2014
Andrew McKenzie was a member of Dr. Alan Howe's lab from 2009 to 2014. He is now a Postdoc at Vanderbilt University.
8/2007-8/2012, Dr. Anthony Morielli’s lab
Thesis Defense August 24, 2012
"Secretin-modulated potassium channel trafficking as a novel mechanism for regulating cerebrallar synapses"
Michael worked in Dr. Anthony Morielli's lab as a technician from August 2004 to July of 2007 and then as a graduate student from August 2007 to August 2012 studying the regulation of voltage gated ion channels. Michael is currently a postdoctoral fellow at Dartmouth College, Lebanon, NH and is studying how dysregulation of the PI3K-mTOR/PTEN pathways leads to changes in synapse formation and function.
7/2007-10/2010, Dr. Alan Howe’s lab
Thesis Defense October 25, 2010
“Identification of 14-3-3 epsilon as a novel in vivo substrate”
Ying was a graduate student in Dr. Alan Howe's lab. She is currently a Clinical Technician at Boston Children's Hospital, Brigham and Women's Hospital.
7/2005-10/2010, Dr. George Wellman’s lab
Thesis Defense August 30, 2010
“Role of voltage-dependent calcium channels in subarachnoid hemorrhage-induced constriction of intracerebral arterioles”
Matt was a Postdoctoral Associate in the laboratory of Dr. Fernando Santana in the Department of Physiology & Biophysics at the University of Washington, following his Postdoctoral Associate position here in the laboratory of Dr. George Wellman in the Department of Pharmacology at the University of Vermont. He is currently a Postdoctoral Fellow at the University of California at Davis.
Rachael Hannah, Ph.D. (Neuroscience)
9/2007-5/2010, Dr. Mark Nelson’s lab
Thesis Defense March 10, 2010
“Prominent influence of potassium channel activity on brain arteriolar diameter”
Rachael was an NIH Postdoctoral Fellow in the laboratory of Dr. Mark Nelson here in the Department of Pharmacology at the University of Vermont. In January 2011, she became an Assistant Professor in the Department of Biology at the University of Maine at Presque Isle, Presque Isle, ME.
Kara Held, Ph.D. (Cell & Molecular Biology)
9/2005-5/2010, Dr. Wolfgang Dostmann’s lab
Thesis Defense March 23, 2010
“Characterization of the spatiotemporal regulation of cyclic guanosine-3’,5’-monophosphate in vascular smooth muscle cells”
Kara is currently a Laboratory Manager at Harvard University. Previously, she was a Postdoctoral Associate in the laboratory of Dr. William Sessa in the Department of Pharmacology at Yale University School of Medicine, New Haven, CT.
1/2004-2/2010, Dr. Mark Nelson’s lab
Thesis Defense January 28, 2010
“Regulation of Urinary Bladder Smooth Muscle Function by Muscarinic Receptors and Ion Channels”
Bernhard was a Postdoctoral Associate in the laboratory of Dr. Gary Mawe in the Department of Anatomy and Neurobiology here at the University of Vermont, and a postdoc at the University of Calgary in Calgary, Alberta Canada. He is currently a Junior Manager for Pharmacology and Toxicology at Bionorica, a pharmaceutical company specializing in phytopharmaca in Germany.
Megan Doczi, Ph.D. (Neuroscience)
9/2004-11/2009, labs of Drs. Deborah Damon and Anthony Morielli
Thesis Defense November 11, 2009
“Subcellular distribution of a voltage-gated potassium channel: the effect of localization on channel function”
Megan was a Postdoctoral Associate in the laboratories of Drs. Cynthia Forehand and Rodney Parsons in the Department of Anatomy and Neurobiology here at the University of Vermont. Currently she is an Assistant Professor of Biology at Norwich University.
Emilee Connors, Ph.D.
9/2003-9/2009, Dr. Anthony Morielli’s lab
Thesis Defense August 21, 2009
“Positive Trafficking Pathways of a Voltage Gated Potassium Channel”
Emily was a Postdoctoral Research fellow in the laboratory of Dr. Richard Lewis in the Department of Molecular & Cellular Physiology at Stanford University, Stanford, CA. She is currently a Senior Medical Writer at ARIAD Pharmaceuticals, Inc., MAP Pharmaceuticals, in the Greater Boston Area, MA.
Shiv Kumar Raidas, M.S (Cell & Molecular Biology Program)
9/2003-8/2008, Dr. Wolfgang Dostmann’s lab
Thesis Defense January 5, 2009
“The interactions of cGMP-dependent protein kinase with novel peptidic substrates and inhibitors”
Shiv is currently a Research Associate III in Analytical Chemistry, Protein Chemistry Sciences, at Regeneron Pharmaceuticals, Inc., in Tarrytown, NY.
Lee Stirling, M.S. (Cell & Molecular Biology Program)
Dr. Anthony Morielli’s lab
Thesis Defense (2009)
“Dual roles for RhoA/Rho-kinase in the regulation trafficking of a voltage-sensitive potassium channel”
Lee is currently a Client Relations Specialist in the Business Development & Outreach office of Laboratory Services at Fletcher Allen Health Care, Burlington, VT.
9/2004-1/2009, Dr. Karen Lounsbury’s lab
Thesis Defense January 30, 2009
“Role of nuclear factor κB in regulation of hypoxia inducible factor-1α and angiogenesis”
Phani was a lab research technician in the lab of Dr. Mercedes Rincon in the Department of Immunobiology here at the University of Vermont. Currently she is a Research Associate in the Department Environmental Health Sciences at the University of South Carolina.
Jaclyn teRiele, M.S.
9/2003-3/2008, Dr. Deborah Damon’s lab
Thesis Defense March 24, 2008
“The contribution of artemin and ephrinA signaling to sympathetic vascular innervation”
Jackie is currently a Counselor in the North Country Science & Technology Entry Program at SUNY Potsdam, Potsdam, NY, and the Laboratory Manager for the Biology Department at St. Lawrence University, Canton, NY.
Sarah Hale, Ph.D. (Cell & Molecular Biology)
9/2002-4/2008, Dr. Karen Lounsbury’s lab
Thesis Defense February 15, 2008
“Effects of Erythropoietin and Glycogen Synthase Kinase-3 on Hypoxia Inducible Factor-1α”
Sarah was a Research Associate in the laboratory of Dr. George Osol in the Department of Obstetrics, Gynecology and Reproductive Sciences here at the University of Vermont, following her Postdoctoral Associate position here in the laboratory of Dr. Karen Lounsbury in the Department of Pharmacology at the University of Vermont. She is currently a Manager in Medical Training at Biogen Idec in the Greater Boston Area, MA.
9/2004-12/2007, Dr. Wolfgang Dostmann’s lab
Thesis Defense December 15th, 2007
“Novel insights into PKG activation and cGMP signaling in response to nitric oxide and atrial natriuretic peptide in vascular smooth muscle cells”
Lydia was an American Heart Association Postdoctoral Fellow here in the laboratory of Dr. Mark Nelson in the Department of Pharmacology at the University of Vermont until December 2012. She is currently living in der Oberpfalz, Germany.
Patricia Rose, RPh, M.S., Ph.D.
9/2001-6/2007, Dr. Karen Lounsbury’s lab
Thesis Defense August 27, 2007
“Gene Expression in Vascular Smooth Muscle: Models of Hypertension and Angiotensin II Signaling”
Pat was an Assistant Professor in the Hofstra School of Medicine, Hempsted, NY, following her NIH Postdoctoral Fellow position here in the laboratory of Dr. Karen Lounsbury in the Department of Pharmacology at the University of Vermont. She is currently in the Miami /Fort Lauderdale area, Florida.
9/2003-5/2007, Dr. Mark Nelson’s lab
Thesis Defense May 4, 2007
“The Role of the Transcription Factor NFAT in the Regulation of UBSM Contractility”
Jeff is currently a Senior Research Scientist at Phenomenex, Inc., Torrance, CA, following his NIH Postdoctoral Fellow position here in the laboratory of Dr. Mark Nelson in the Department of Pharmacology at the University of Vermont.
Sharon Cawley, Ph.D. (Cell & Molecular Biology)
9/2001-5/2007, Dr. Wolfgang Dostmann’s lab
Thesis Defense March 5, 2007
“The Intracellular Dynamics of Guanosine-3’,5’-monophosphate (cGMP)in Vascular Smooth Muscle”
Sharon was a Post Doctoral Fellow in the Cardiovascular Research Center at Massachusetts General Hospital / Harvard Medical School. She received the Ruth L. Kirshstein National Research Service Award. She is a past Instructor at the Harvard Medical School in Anesthesia and Critical Care. Currently she is a Post Doctoral Scientist for Acceleron Pharma in, Cambridge, MA.
9/2004-5/2006, Dr. Anthony Morielli’s lab
Thesis Defense August 16th, 2006
“Analysis of Kv1.2-cortactin interactions using FRET-based microscopy”
Jonathan is currently working on his Ph.D. He is a Research Assistant for Ebert-May Lab at Michigan State University and the Program Coordinator for the Summer Experience for Undergraduates at Great Lakes Bioenergy Research Center (GLBRC).
9/2001-10/2006, Dr. Anthony Morielli’s lab
Thesis Defense August 14th, 2006
“Kv Channel Regulation Via Ubiquitin Dependent Endocytosis”
Edmund is currently a Postdoctoral Fellow in the laboratory of Dr. Gail Mandel (http://www.ohsu.edu/xd/research/centers-institutes/vollum/faculty/mandellab.cfm) in the Vollum Institute at the Oregon Health & Science University, Portland, OR.
Christy Barlow, Ph.D. (Cell & Molecular Biology)
9/2002-5/2006, Dr. Karen Lounsbury’s lab
Thesis Defense August 2, 2006
“Role of Oxidant and Asbestos-induced CREB Activation in the Pathogenesis of Lung Disease”
Christy is currently working in environmental services in the Greater Denver area. She was a Postdoctoral Associate in the laboratory of Dr. Richard Anderson (http://molpharm.wisc.edu/people/faculty/anderson/anderson.html) in the Department of Pharmacology at the University of Wisconsin, Madison, WI.
Renee Pulver-Kaste, Ph.D.
9/2000-5/2005, Dr. Karen Lounsbury’s lab
Thesis Defense January 21st, 2005
“Calcium-Dependent Gene Modulation in Vascular Smooth Muscle”
Renee is currently a Senior Associate Director in the Research department at Boehringer Ingelheim Pharmaceuticals, Inc., Danbury, CT.
9/1998-5/2005, Dr. Wolfgang Dostmann’s lab
Thesis Defense May 13, 2005
“Construction of fret-based cGMP indicators and their use to reveal the spatial and temporal dynamics of cGMP in vascular smooth muscke cells”
Carolyn has used her writing skills and scientific knowledge for the Genzyme Corp. as a Scientific Publications Manager for the Transplant Sales and Marketing Team, then as a Medical Writer and Scientific Communications Manager for the Gaucher Disease Medical Affairs Team.
Carolyn is currently Head of Operations at Novartis Institutes for BioMedical Research, Cambridge, MA and has been with the company since 2008. Her current responsibilities include internal communications, budget mangement, research and IT project management, drug discovery course delivery, and general departmental problem resolution.
Kristen Pavelock, Ph.D.
9/1996-6/2003, Dr. Victor May’s lab
Thesis Defense September 16, 2002
“Vascular Endothelial Growth Factor (VEGF) Receptor Expression, Regulation and Function in Vascular and Neuronal Networks”
Kristen is currently a pharmacist at Shaw’s Osco, Colchester, VT.
9/1997-9/2001, Dr. John McCormack’s lab
Thesis Defense August 3, 2001
“Analytical and Pharmacokinetic Studies with Cytochlor and Tachpyr,
Two Novel Anti-Cancer Agents”
Jodi is currently a Principal Research Scientist in the Center for Drug Discovery at Northeastern University, Boston, MA.
Gerald Herrera, Ph.D. (Molecular Physiology and Biophysics)
9/1997-5/2001, Dr. Mark Nelson’s lab
Thesis Defense March 28, 2001
“Regulation of Urinary Bladder Smooth Muscle Function By Subcellular Calcium Signals and Calcium-Dependent Potassium Channels”
Gerry is currently the Vice President of Research and Development at Med Associates, Inc., St. Albans, VT, and is President of Catamount Research & Development, Inc., St. Albans, VT. In addition, he is an Adjunct Assistant Professor here in the Pharmacology Department at the University of Vermont.
9/1997-5/2001, Dr. Mark Nelson’s lab
Thesis Defense April 10, 2001
“Dynamic Regulation of Calcium-Dependent Transcription Factors by Differential Calcium Signaling Modalities in Smooth Muscle”
Andrá is currently a Senior Research Scientist in Pharmacology at Merck & Co., Inc., Rahway, NJ.
Laura (Cartin) Jaggar, Ph.D.
2/1995-7/1998, Dr. Mark Nelson’s lab
Thesis Defense December 16, 1999
“Coupling of Ca2+ to CREB Activation and Gene Expression in Intact Cerebral Arteries from Mouse: Roles of Ryanodine Receptors and Voltage-Dependent Ca2+ Channels”
Laura is currently a Secondary School Science Teacher in Memphis, TN, after a Postdoctoral Associate position in the Department of Pharmacology at the University of Tennessee, Memphis.
Lynne M. Robertson, Ph.D.
9/1994-6/1999, Dr. John McCormack’s lab
Thesis Defense June 10, 1999
“Development of a Monolithic Transdermal Drug Formulation”
Lynne is currently President of Gwen Ryan Solutions, LLC, Bridgewater, NJ, and a regulatory consultant at Novaquest.
2/1995-7/1998, Dr. Mark Nelson’s lab
Thesis Defense July 24, 1998
“Molecular Aspects of Adriamycin Action: Evidence for a Functionally Inducible Temperature-sensitive p53 Mutant in a Murine Lymphocytic Leukemia Cell Line”
David is currently a Research Assistant Professor here in the laboratory of Dr. Mark Nelson in the Department of Pharmacology at the University of Vermont following his Postdoctoral Associate position here in Dr. Nelson’s lab.
PHARMACOLOGY ALUMNI/AE (1961-1997)
Kory Engelke, Ph.D.
11/1990-3/1997, Dr. Miles Hacker’s lab
Thesis Defense March 14, 1997
“Mechanistic Studies on a Novel Class of Anti-Cancer Agents: The Aza-Anthrapyrazoles
Kory is currently launching the Product Development and Consulting Services at AVANZA Laboratories, Gaithersburg, MD.
Kai-Ming Chou, Ph.D. (Cell & Molecular Biology)
1993-1997, Dr. Miles Hacker’s lab
Thesis Defense November 7, 1997
“Structural Studies on Drug-Target Interactions and Intracellular Distribution”
Kai-Ming is currently Assistant Professor in the Department of Pharmacology and Toxicology at Indiana University, Indianapolis, IN.
Todd Rossignol, Ph.D. (Cell & Molecular Biology)
Thesis Defense September 5, 1997
“Modulation of Cloned K Channels by Muscarinic Receptors”
Laura Shostak , Ph.D.
9/1992-6/1997, Dr. John McCormack’s lab
Thesis Defense August 29, 1997
“Biochemical and Analytical Characteristics of Phosphorothioate Oligodeoxynucleotides”
Laura is currently a Regional Medical Scientist at GlaxoSmithKline, Rochester, NY.
Regent Laporte, Ph.D.
1989-1995, Dr. Ismail Laher’s lab
Thesis Defense July 10, 1997
“The Sarcoplasmic Reticulum Modulates Vascular Contraction Due to Calcium Influx”
Regent is currently Associate Director of In Vivo Pharmacology, Ferring Research Institute, Inc., San Diego, CA.
Diehl, Nicole Lynn Racine (1996) Receptors and G protein interactions : studies of the alpha-1 adrenergic and vasoactive intestinal peptide receptors [PhD] Pharmacology. Living in Whiteford, MD.
Ding, Andrew Q. (1996) Flow induced contraction is associated with activation of voltage-dependent Ca²⁺ channels and an increase in intracellular Ca²⁺ concentration in the blood vessel wall [MS] Pharmacology. Working for Groton Labs, Pfizer Global Research and Development, Groton, CT.
Xuan, Yongzhi (1996) Studies on the transport of and resistance to methotrexate in L1210 cells [PhD] Pharmacology. Working at University of Illinois, Chicago, IL.
Villagra, Lucy F. (1995) Differential mechanisms of multidrug resistance are expressed during stepwise selection of KB-3-1 cells with adriamycin [MS] Pharmacology
Hess, Jean Anne (1995) Signal transduction pathways involved in the mechanism of action of adriamycin and in multidrug resistance [PhD] Pharmacology
Song, James Joo-Suk (1994) The role of protein kinase C in the modulation of DNA topoisomerase II in human leukemic CCRF-CEM cells and resistant sublines [PhD] Pharmacology
Wellman, George C. (1990) Biochemical and functional evidence for a cholinergic neurodilator pathway in systemic arteries [MS] Pharmacology
Van Riper, Dee A. (1990) Agonist and neurogenic responses of rabbit cerebral arteries : variation with branch order and characterization of nerves and putative neurotransmitters [PhD] Pharmacology
Schimdt, Wendelyn Jean (1989) Ligand modulation of the stability, cytotoxicity, DNA reactivity, and uptake of a series of platinum antitumor complexes [PhD] Pharmacology
Brann, Mark R. (1984) Neuronal substrates of dopamine-mediated psychomotor behavior [PhD] Pharmacology
Gray, Mary Ann (1984) Adriamycin cardiotoxicity [PhD] Pharmacology
Heusner, James J. (1983) Preclinical studies on lipid soluble antifolates [PhD] Pharmacology
Mulcahy, Linda S. (1983) Liver mitochondrial DNA polymerase activity in response to chemical injury [PhD] Pharmacology
Kramer, Robert A. (1982) Studies on the cellular localization of mexed-function oxidase activity in mouse lung [PhD] Pharmacology
Garfield, Mark K. (1982) The effect of extracellular ATP on neuroblastoma x glioma hybrid cells [MS] Pharmacology
Berger, Wendy Hope (1981) Studies on the role of growth hormone in regulating the inhibition of microsomal enzyme activity in response to corynebacterium parvum [MS] Pharmacology
Stanwyck, T. Scott (1979) Stimulation of the superior cervical ganglion and the adrenal medulla of normotensive and hypertensive rats by angiotensin II [MS] Pharmacology
Allen, Barbara A. (1976) Oxidation of pteridines and benzaldehydes by flavoproteins. [MS] Pharmacology
Knipe, Jay O. (1975) Oxidation of pteridine derivatives in vivo. [PhD] Pharmacology
Ackerly, John Arnold (1974) Modulation by naturally occurring substances of the contractile effects of agonists on certain rat and rabbit muscles. [PhD] Pharmacology
Hodnett, Charles Nicholas (1974) Oxidation of pteridine derivatives by mammalian aldehyde and xanthine oxidase. [PhD] Pharmacology
Tulp. Orien Lee., (1974) Characteristics of estrogen formation in placental cell suspensions. [PhD] Pharmacology
Richter, Walter E. (1974) Enzymatic studies with pteridines and other related heterocycles. [PhD] Pharmacology
Benjamin, David Marshall (1973) A study of approaches to the chemical analysis of aminoglycoside antibiotics. [PhD] Pharmacology
Block, Alan Joseph (1972) Effect of histamine on contractile responses of cat skeletal muscle to intravascularly administered agonists. [PhD] Pharmacology
Brazier, Johnna Blethen. (1972) Two types of pyruvate kinase in schistosomes and filariae. [MS] Pharmacology
Chello, Paul Larson (1971) Comparative properties of trypanosomal and mammalian thymidine kinases. [PhD] Pharmacology
O'Brien, Robert Allyn (1971) The uptake of pharmacologically-active substances by human blood platelets [PhD] Pharmacology
Benjamin, David Marshall (1970) Studies of the molecular interaction between warfarin and cholestyramine. [MS] Pharmacology
Aiken, James Wavell. (1969) The sensitivity of adrenergic and cholinergic neurons in the cat stellate ganglio to chemical stimuli. [PhD] Pharmacology
Kupferman, Allan (1967) Interactions of selcted local anesthetics with adrenergic amines on the blood pressure of the rat and in isolated hearts and aortic strips of this species. [PhD] Pharmacology
Robinson, Donald Stetson (1966) The effect of phenobarbital administration on the control of coagulation achieved during warfarin therapy in man. [MS] Pharmacology
Aronson, Carl Edward (1965) Studies on the metabolism of methionine, its analogues, and other amino acids by Trypanosoma equiperdum. [PhD] Pharmacology
Heaton, Robert William (1962) Effects of histamine upon the cardiovascular system of swine and the intravenous LD50 in swine. [MS] Pharmacology
Colclough, Norma Vesey (1961) The effect of S, 2-aminoethylisothiouronium dibromide (AET) on the peripheral blood and bone marrow cells of the rabbit following CO-60 gamma radiation. [MS] Pharmacology
Last modified November 20 2014 03:46 PM